Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,984 public trials 1,830 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

NCT00101270

Conditions: Astrocytoma, Burkitt Lymphoma, Childhood Burkitt Lymphoma, +115 more
Locations: COG Phase I Consortium Arcadia, California, United States

View Trial Details

Completed

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia

NCT00079404

Conditions: Acute Undifferentiated Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: COG Phase I Consortium Arcadia, California, United States

View Trial Details

Completed

Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia

NCT00089349

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: COG Phase I Consortium Arcadia, California, United States

View Trial Details

Completed

Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

NCT00081133

Conditions: Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +21 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression Anastomosis

NCT01301417

Conditions: Colitis, Colitis, Ulcerative, Colonic Diseases, +40 more
Locations: Southern Regional Medical Center Riverdale, Georgia, United States

View Trial Details

Completed

Pyroxamide in Treating Patients With Advanced Cancer

NCT00042900

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +90 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma

NCT00058227

Conditions: B-cell Chronic Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +71 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease

NCT00005613

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
Locations: Florida Cancer Specialists Fort Myers, Florida, United States

H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors

NCT00093821

Conditions: Childhood Chronic Myelogenous Leukemia, Childhood Desmoplastic Small Round Cell Tumor, Desmoplastic Small Round Cell Tumor, +36 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Oblimersen in Treating Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia

NCT00062244

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Howard University Hospital Washington D.C., District of Columbia, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions